This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Caparrós, T. Articles by Grau, T. Search for Related Content PubMed PubMed Citation Articles by Caparrós, T. Articles by Grau, T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE Medline Plus Health Information Antioxidants Dietary Fiber Dietary Proteins Social Bookmarking                         What's this?

Early Enteral Nutrition in Critically III Patients With a High-Protein Diet Enriched with Arginine, Fiber, and Antioxidants Compared With a Standard High-Protein Diet. The Effect on Nosocomial Infections and Outcome

Fundación Jimenez Díaz, tomascaparros{at}terra.es

Jorge Lopez, MD

Hospital Severo Ochoa, Leganes

Teodoro Grau, MD

Hospital Universitario de Getafe, Madrid, Spain

Background: This study was designed to evaluate the effects of a high-protein formula enriched with arginine, fiber, and antioxidants compared with a standard high-protein formula in early enteral nutrition in critically ill patients. Methods: For this study, 220 patients were enrolled in a prospective, multicenter, single-blind, randomized trial in 15 Spanish intensive care units (ICUs). The primary endpoints were the incidence density rates of nosocomial infections, ICU and hospital length of stay, ICU and in-hospital mortality, and mortality at 6-month follow-up. Results: The patients in the control and study groups had similar baseline characteristics. The study group had a lower incidence of catheter-related sepsis (0.4 episodes/1000 ICU days) than the control group (5.5 episodes/1000 ICU days), with a relative risk (RR) of 0.07 (95% confidence interval [CI] 0.01 to 0.54, p < .001). There were no differences in the incidence of ventilator-associated pneumonia, surgical infection, bacteremia, or urinary tract infections between the 2 groups. ICU mortality (16% in the study group versus 21% in the control group; RR 1.5, CI 95% 0.7 to 2.9) and in-hospital mortality (21% in the study group versus 30% in the control group; RR 1.6, CI 95% 0.9 to 3) were similar without differences in survival at 6-month follow-up (75% in the study group versus 68% in the control group, p = .15). Patients in the study group who were treated for 2 or more days showed a strong trend for better survival at 6-month follow-up (76% in the study group versus 67% in the control group, p = .06). Medical patients treated with the study diet had better survival than medical patients in the control group (76% in the study group versus 59% in the control group, p < .05). Conclusions: Critically ill patients fed a high-protein diet enriched with arginine, fiber, and antioxidants had a significantly lower catheter-related sepsis rate than patients fed a standard high-protein diet. There were no differences in mortality or ICU and hospital length of stay. The subgroup of patients fed the study diet for >2 days showed a trend toward decreased mortality. (Journal of Parenteral and Enteral Nutrition 25:299-309, 2001)

Journal of Parenteral and Enteral Nutrition, Vol. 25, No. 6, 299-309 (2001)
DOI: 10.1177/0148607101025006299


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. A. McClave, R. G. Martindale, V. W. Vanek, M. McCarthy, P. Roberts, B. Taylor, J. B. Ochoa, L. Napolitano, G. Cresci, the A.S.P.E.N. Board of Directors, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) JPEN J Parenter Enteral Nutr, May 1, 2009; 33(3): 277 - 316. [Full Text] [PDF]

				M. Zhou and R. G. Martindale Arginine in the Critical Care Setting J. Nutr., June 1, 2007; 137(6): 1687S - 1692S. [Abstract] [Full Text] [PDF]

				C. W. Van Way III Of Glutamine and Arginine JPEN J Parenter Enteral Nutr, May 1, 2005; 29(3): 218 - 219. [Full Text] [PDF]

				S. Bengmark and R. Martindale Prebiotics and Synbiotics in Clinical Medicine Nutr Clin Pract, April 1, 2005; 20(2): 244 - 261. [Abstract] [Full Text] [PDF]

				G. P. Zaloga Improving Outcomes With Specialized Nutrition Support JPEN J Parenter Enteral Nutr, January 1, 2005; 29(1_suppl): S49 - S52. [Full Text] [PDF]

				K. C McCowen and B. R Bistrian Immunonutrition: problematic or problem solving? Am. J. Clinical Nutrition, April 1, 2003; 77(4): 764 - 770. [Abstract] [Full Text] [PDF]

				Enriched High-Protein Enteral Diets for Critically Ill Patients Journal Watch Gastroenterology, January 16, 2002; 2002(116): 7 - 7. [Full Text]